Social media butterfly

How this Houston Realtor uses technology to interact with an increasingly younger clientele

Using social media — the right way — can help foster better relationships with millennial clients. Tracy Le Blanc/Pexels

According to a 2018 AdWeek article by Dario Cardile, the millennial population accounts for 66 percent of the first-time homebuyer's market, and industry research suggests the millennial generation chooses Instagram as its top social media platform.

I have learned the importance of adapting to modern techniques including adopting the social media climate and using it to my advantage, both as an individual and as a company. It's not just because social media has grown to be a leading component of brand promotion but because it's my direct line of communication to my current and future clients.

Today, social media, particularly Instagram, is not just a small promotional tool among many, but rather a major engagement platform for the real estate industry. As a real estate agent in the competitive Houston market, I use Instagram as another avenue to reach a larger audience, connect with potential new clients and showcase my listings in a unique and organic way that complements my overall approach.

I have found that my Instagram followers enjoy seeing both sides of me: the professional and personal. Keeping up with my account isn't as simple as posting every so often. People like to know and trust who they are working with and it's been a fun challenge to balance (and blur) my work and personal life to give my followers and clients a behind-the-scenes look at my career and lifestyle. I've learned that they want to know who you are in and out of the office and I've even been asked for tips outside of real estate such as make up, skincare, and fitness.

One way I organize my Instagram account is through categorized story highlights. Because I post frequent stories, it's important to feature and distinguish the most notable ones in order for people to find what they are looking for, whether it be things I have to offer as a Realtor or what I do in my free time. I've created story categories such as "Listings," "Nan Properties," "Fitness," "Beauty," and "In the News" in order for easy access.

My posts on my feed often feature pictures of me in both the work and social environment. I like to create fun captions that encourage followers to check out my story in order to see the latest listings. This makes the work aspect of my life exciting and engaging.

Because real estate is very focused on visual content, videos and photos of listings provide a quick and convenient way for clients to view listed properties. This engagement is incredibly important to keep my real estate company top-of-mind for clients, especially those who are millennials. In addition, I feature pictures of my family and adorable puppy in order to show my followers what is important in my life.

Of course, it's necessary to set boundaries when it comes to sharing personal information on social media. I've taken a lot of precautions when it comes to sharing my personal life and my biggest rule is to avoid sharing in real time when possible.

A major tip that I would pass on to any Realtors or client-focused professionals getting involved with social media is to have fun. People love to see your excitement about what you do. Be consistent with your posts and as more followers engage with your content, take note of what they enjoy and would like to see you posting about frequently.

------

Nancy Almodovar is the president and CEO of Nan and Company Properties in Houston.

Trending News

 
 

Promoted

A research team housed out of the newly launched Rice Biotech Launch Pad received funding to scale tech that could slash cancer deaths in half. Photo via Rice University

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

Trending News

 
 

Promoted